Best Probiotics for Constipation: Evidence-Based Strains That Actually Work
What peer-reviewed research says about the specific probiotic strains most likely to restore regularity, reduce bloating, and support lasting gut motility
Constipation affects an estimated 14–16% of adults worldwide, making it one of the most common gastrointestinal complaints seen in clinical practice.[1] For many people, it means more than occasional inconvenience—it means days of discomfort, abdominal bloating, straining, and a nagging sense that something in the gut is simply not working right.
Over the past decade, research has firmly established a connection between the gut microbiome and intestinal motility. Constipation is now understood not merely as a fiber or hydration issue, but as a condition closely tied to gut dysbiosis—an imbalance in the microbial communities that regulate how the colon moves, secretes, and processes stool. That insight opens a meaningful therapeutic door: by restoring balance with targeted probiotic strains, it may be possible to address constipation at one of its root causes.
But "probiotics" is not a monolithic category. Strains vary enormously in their mechanisms, their clinical track records, and their relevance to constipation specifically. This guide walks through the peer-reviewed evidence on which probiotic strains—specifically those found in MicroBiome Restore's 26-strain formula—have been most meaningfully studied for constipation relief, and what that research actually shows.
Key Takeaways
- Probiotics significantly outperform placebo for constipation. A 2024 systematic review and meta-analysis of 10 RCTs found that probiotics were significantly superior to placebo in constipation management, with a p-value below 0.05.[1]
- Bifidobacterium lactis is the most consistently supported single strain for increasing stool frequency in adults with chronic constipation, with a significant effect identified in a 30-RCT meta-analysis.[2]
- Lactobacillus reuteri increased bowel movements by 2.6 per week over placebo in a double-blind RCT of adults with functional constipation.[3]
- Bifidobacterium longum significantly improved bowel movements in elderly patients with chronic constipation in a randomized controlled trial.[4]
- The gut microbiota directly regulates intestinal motility through short-chain fatty acid production, serotonin synthesis, and enteric nervous system signaling—explaining the biological rationale for probiotic intervention.[5]
- Synbiotics (probiotics + prebiotics) outperform probiotics alone. Multiple analyses confirm that pairing probiotic strains with prebiotic fibers improves colonization, SCFA production, and constipation outcomes.[2]
- Filler-free formulations matter. Inactive ingredients like microcrystalline cellulose and magnesium stearate found in many probiotics can undermine the gut health you're trying to restore.
Why the Gut Microbiome Matters for Constipation
For a long time, constipation was treated as a problem of insufficient fiber, fluid, or physical activity. Those factors are still relevant—but the research has moved well beyond them. We now understand that the microbial ecosystem of the gut plays a direct, bidirectional role in how the colon moves.
Studies comparing the gut microbiota of constipated individuals to healthy controls consistently show meaningful differences. People with functional constipation tend to have reduced populations of Bifidobacterium and Lactobacillus species, alongside elevations in methane-producing organisms that slow gut transit, and alterations in the bacteria responsible for producing short-chain fatty acids (SCFAs) and serotonin.[5] These aren't incidental findings—they point to specific mechanisms through which gut dysbiosis contributes to sluggish bowel function.
The Dysbiosis–Constipation Connection
A 2021 review published in Gastroenterology Report summarized the evidence on gut microbiota and functional constipation, identifying several pathways through which microbial imbalance contributes to the condition: altered bile acid metabolism, reduced SCFA production, disrupted serotonin signaling, and excess methane gas—each capable of slowing colonic transit.[5] Understanding these pathways makes it easier to understand why specific probiotic strains work, and how they differ from conventional laxatives that simply force evacuation without addressing underlying microbial function.

The practical takeaway: treating constipation with a targeted probiotic supplement isn't a workaround—it's a scientifically grounded strategy aimed at the microbial roots of the problem. For a deeper look at how microbial imbalance signals itself, see our guide on 12 signs your gut needs probiotics.
How Probiotics Address Constipation Mechanistically
Probiotics don't work by acting as stimulant laxatives. They work by restoring microbial function in ways that collectively support more regular, comfortable bowel movements. A 2017 review published in Advances in Nutrition on mechanisms of probiotic action in gut motility identified several key pathways:[6]
The Serotonin–SCFA–Motility Axis
Approximately 95% of the body's serotonin (5-HT) is produced in the gut, where it acts as a key regulator of intestinal peristalsis. Beneficial bacteria—particularly Bifidobacterium and Lactobacillus species—support serotonin synthesis by producing metabolites like short-chain fatty acids (SCFAs: acetate, propionate, butyrate) that stimulate enterochromaffin cells to release 5-HT. This serotonin then activates motor neurons in the enteric nervous system, triggering the propulsive contractions that move stool forward. Constipated individuals often show both reduced SCFA-producing bacteria and lower serotonin availability in the colon—a dual deficit that probiotic supplementation can help correct.[5][6]

Four Core Mechanisms
1. Short-chain fatty acid production. When probiotic bacteria ferment prebiotic fibers in the colon, they produce SCFAs that lower colonic pH, stimulate smooth muscle contractions, and accelerate gut transit. The prebiotic-rich environment provided by fibers like inulin (found in Jerusalem artichoke) and acacia fiber directly fuels this process.
2. Serotonin upregulation. Probiotic metabolites trigger 5-HT release from enterochromaffin cells, directly stimulating the enteric reflex arcs that drive peristaltic movement through the colon.[6]
3. Bile acid modulation. Gut bacteria metabolize bile acids in ways that affect colonic secretion and transit. A healthy microbiome maintains bile acid diversity that supports normal bowel function; dysbiosis disrupts this balance.[5]
4. Methane suppression. Methanogenic archaea in the gut produce methane gas, which acts as a neuromuscular transmitter that slows intestinal transit. Rebalancing the microbiome with beneficial bacteria competitively suppresses these methane producers, helping to restore normal motility.[5]
Understanding these mechanisms also illuminates why the combination of probiotics with prebiotics—called a synbiotic—tends to outperform probiotics alone. For more on what dysbiosis looks like and how it contributes to a range of gut symptoms, see our article on Bifidobacterium deficiency and Lactobacillus deficiency signs and symptoms.
Best Probiotic Strains for Constipation: The Clinical Evidence
Not every probiotic strain has been studied for constipation, and the ones that have show very different levels of evidence. Below are the strains present in MicroBiome Restore with the strongest or most relevant clinical evidence for constipation, IBS-C, and related motility issues.
Bifidobacterium lactis: The Most Consistently Supported Single Strain
Bifidobacterium lactis has more constipation-specific clinical data behind it than almost any other single probiotic strain. A 2022 systematic review and meta-analysis from King's College London, encompassing 30 randomized controlled trials investigating probiotics for chronic constipation in adults, identified B. lactis specifically as having a significant effect on stool frequency—a finding that did not hold for probiotic mixtures or other individual strains tested in that analysis.[2]
The proposed mechanism involves B. lactis's capacity to modulate colonic motility through direct interaction with host physiological systems, rather than simply altering colonic pH or water content. An ex vivo model found that B. lactis extract markedly increased the contractile amplitude of synchronous contractions spanning the proximal colon to the rectum.[7] This motility-stimulating effect is strain-specific—a reminder that the benefit documented for one Bifidobacterium subspecies cannot be assumed for the genus as a whole.
Read more about the broader clinical evidence for Bifidobacterium lactis benefits for gut health.
Lactobacillus reuteri: Clinically Meaningful Increase in Bowel Movement Frequency
Lactobacillus reuteri DSM 17938 has accumulated substantial evidence across age groups for its effect on bowel movement frequency in functional constipation. In adults, a double-blind, placebo-controlled RCT of 40 patients with functional constipation (diagnosed per Rome III criteria) found that L. reuteri supplementation increased bowel movements by a mean of 2.6 per week over placebo at four weeks—a clinically meaningful improvement that was statistically significant.[3]
Research in Frontiers in Cellular and Infection Microbiology on L. reuteri in digestive system diseases identified two proposed mechanisms: modulation of the serotonin (5-HT) pathway, and direct excitation of colonic enteric neurons—both of which contribute to the accelerated intestinal transit seen in clinical trials.[8]
Bifidobacterium longum: Improving Bowel Function, Especially in Aging Guts
Bifidobacterium longum is one of the dominant Bifidobacterium species in a healthy adult gut—and one of the first to decline with age. A 2023 randomized, double-blind, placebo-controlled trial in The American Journal of Gastroenterology evaluated B. longum BB536 in 80 elderly patients with chronic constipation. While the primary composite endpoint fell just short of significance, probiotic supplementation significantly improved bowel movements—stool frequency—over the four-week intervention period.[4]
The researchers noted that improvement in bowel movement was likely mediated by metabolite production rather than simple changes in microbiota composition at the genus level, suggesting that B. longum's SCFA output—particularly acetate and lactate—may be the active driver of its motility effects.[4] For broader context on this strain and its role in gut health, see our article on Bifidobacterium longum.
Lactobacillus acidophilus and Lactobacillus casei: Relief for IBS-C
For those whose constipation is rooted in irritable bowel syndrome with predominant constipation (IBS-C), the combination of L. acidophilus and L. casei has been specifically evaluated. A study published in PLOS ONE found that 97.4% of IBS-C participants who consumed a formula containing L. acidophilus LA-5 and L. paracasei L. CASEI-01 daily for 30 days experienced improvement in constipation-related symptoms, with significant reductions in intestinal transit time and fecal pH.[9]
A broader 12-week RCT in 113 IBS patients evaluated a combination of L. acidophilus CL1285, L. casei LBC80R, and L. rhamnosus CLR2 and found a therapeutic advantage across IBS subtypes—including IBS-C—for endpoints including stool consistency and frequency.[10] The clinical evidence behind Lactobacillus acidophilus and its dosing is explored further in our dedicated article.
Lactobacillus rhamnosus: Gut Transit and IBS Symptom Reduction
Lactobacillus rhamnosus has one of the broadest bodies of clinical evidence in the probiotic literature. In the context of constipation and IBS-C, it has appeared across multiple multi-strain trials demonstrating improvements in stool consistency, frequency, and abdominal comfort—most notably in combination with L. acidophilus and L. casei.[10] Its mechanism appears to include both immune modulation and direct normalization of gut transit via enteric nervous system interactions. See our dedicated article on Lactobacillus rhamnosus benefits for the full clinical picture.
Lactobacillus plantarum: Intestinal Barrier Support and Transit Normalization
Lactobacillus plantarum is notable for its robust ability to colonize the intestine and produce bioactive compounds that support mucosal integrity and barrier function. In the context of constipation, it has been evaluated as a component of multi-strain synbiotic formulas, where it contributes to the SCFA production and microbiota rebalancing that support normal colonic motility. The extensive research on L. plantarum health benefits spans anti-inflammatory, anti-dysbiotic, and gut motility-relevant mechanisms.
Bacillus coagulans: Spore-Forming Stability with IBS Benefits
Bacillus coagulans is a spore-forming probiotic that survives harsh conditions—including stomach acid and heat—making it a reliably bioavailable option. A network meta-analysis in Frontiers in Pharmacology evaluating probiotics across multiple IBS subtypes included B. coagulans among the strains demonstrating significant global IBS symptom improvement.[11] Its spore-forming nature means it reaches the colon with high viability, where it supports SCFA production and microbiota balance. See our article on Bacillus coagulans benefits for strain-specific evidence.
Streptococcus thermophilus: A Supporting Role in Gut Motility
Streptococcus thermophilus is most commonly associated with lactose digestion and fermented food, but it also plays a supporting role in gut motility by producing lactic acid and supporting a favorable colonic environment. It has appeared in multi-strain constipation trials and was identified in a meta-analysis of maternal probiotic supplementation as contributing positively to gut microbiome composition. While less studied as a solo constipation intervention, it enhances the overall fermentative environment when combined with Bifidobacterium and Lactobacillus strains—the synergy that makes multi-strain formulas more effective than single-strain products. The full evidence for Streptococcus thermophilus is covered in our dedicated article.

| Strain (in MicroBiome Restore) | Constipation-Relevant Benefit | Key Evidence |
|---|---|---|
| Bifidobacterium lactis | Increases stool frequency; stimulates colonic contractions | Significant stool frequency effect in 30-RCT meta-analysis[2] |
| Lactobacillus reuteri | Increases bowel movement frequency; modulates serotonin and ENS | +2.6 bowel movements/week vs. placebo (RCT)[3] |
| Bifidobacterium longum | Improves stool frequency; SCFA-mediated motility | Significant bowel movement improvement in elderly RCT[4] |
| L. acidophilus + L. casei | Reduces intestinal transit time; IBS-C symptom improvement | 97.4% IBS-C improvement rate; significant transit time reduction[9] |
| Lactobacillus rhamnosus | Stool consistency and frequency; IBS-C symptom relief | Therapeutic advantage vs. placebo for stool outcomes (RCT)[10] |
| Lactobacillus plantarum | Intestinal barrier support; SCFA production; motility normalization | Multi-strain synbiotic trials; anti-dysbiotic evidence |
| Bacillus coagulans | Global IBS symptom relief including constipation symptoms | Significant global IBS improvement (network meta-analysis)[11] |
| Streptococcus thermophilus | Lactic acid production; fermentative environment support | Multi-strain motility and microbiome composition trials |
All 8 of These Strains. Plus 18 More. In One Filler-Free Formula.
MicroBiome Restore delivers 26 clinically studied probiotic strains—including every strain listed above—at 15 billion CFU per serving, paired with 7 certified organic prebiotic sources. No microcrystalline cellulose. No magnesium stearate. No titanium dioxide. Just strains and the substrates to fuel them.
Probiotics for Constipation and Bloating: The Overlap
Constipation and bloating are closely related, and they often co-occur in IBS and functional gut disorders. Slow transit means longer fermentation time in the colon, which can increase gas production and abdominal distension. Probiotics that improve transit time also tend to reduce bloating—but some strains have been studied specifically for this combination.
The combination of Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 was evaluated in a double-blind, placebo-controlled clinical trial in patients with functional bowel disorders. The probiotic group experienced significant improvement in bloating severity at both 4 weeks and 8 weeks compared to placebo—with the effect holding in the IBS subgroup analysis.[12] Both of these strains are well-represented within the Bifidobacterium and Lactobacillus genera of MicroBiome Restore.
For more on the specific mechanisms and clinical evidence around probiotic intervention for gas and distension, see our dedicated article: probiotics for bloating relief—clinical strains and evidence.
Why Does the Prebiotic Component Matter So Much for Bloating?
The way prebiotics interact with probiotic strains determines whether fermentation produces a balanced output of SCFAs—or an excessive output of gas. Highly fermentable prebiotics introduced too quickly can temporarily worsen bloating before conditions improve. MicroBiome Restore uses a carefully curated prebiotic blend—including acacia fiber from Acacia senegal (known for gentle fermentation suitable for sensitive digestive systems), Jerusalem artichoke, maitake mushroom, fig fruit, bladderwrack, Norwegian kelp, and oarweed—designed to fuel Bifidobacterium and Lactobacillus growth without triggering the excessive gas production associated with certain soluble fibers at high doses. Acacia fiber in particular has been specifically studied for its prebiotic properties in sensitive gut environments.
What to Look for in a Probiotic for Constipation
The probiotic market is crowded, and most products are not formulated with the clinical evidence on constipation in mind. When evaluating a probiotic specifically for constipation and gut motility, several factors matter more than others.
Strain Specificity
As the King's College London meta-analysis demonstrated, not all probiotics—and not even all Bifidobacterium strains—show meaningful effects on stool frequency. The evidence supports specific genera and strains, particularly Bifidobacterium lactis and Lactobacillus reuteri, as well as multi-strain synbiotic formulas.[2] A probiotic that lists only genus-level information (e.g., just "Lactobacillus") without specifying species and strain provides no real assurance of constipation-relevant activity.
Multi-Strain vs. Single-Strain
For functional constipation, multi-strain formulas that include both Bifidobacterium and Lactobacillus species have consistently appeared in the literature for IBS and broader gut motility benefits. Single-strain products have the advantage of more targeted evidence, but the gut is an ecosystem—multiple microbial niches need to be populated for lasting microbiome restoration. Our article on single vs. multi-strain probiotics covers this tradeoff in depth.
Prebiotic Support (Synbiotic Formulation)
The 2022 meta-analysis specifically analyzed synbiotics (probiotic + prebiotic combinations) alongside probiotics alone and found that synbiotic supplementation further improved constipation response rates.[2] The addition of prebiotic fiber provides the fermentation substrate that probiotic bacteria need to produce the SCFAs and other metabolites that drive motility benefits. Looking for a formula that incorporates prebiotics—particularly those that are certified organic and well-tolerated—means you're addressing both sides of the gut microbiome equation. Learning to read probiotic supplement labels and identify the difference between genuine prebiotic sources and filler ingredients is worth the effort.
Capsule Technology and Stability
Probiotic bacteria must survive stomach acid before they can colonize the colon where they're needed. Many conventional gelatin capsules dissolve prematurely in the stomach, delivering far fewer viable organisms than the label claims. Pullulan capsules—like those used in MicroBiome Restore—are naturally fermented from tapioca, provide delayed-release properties, and are prebiotic themselves, making them a genuinely superior delivery mechanism for probiotic organisms.
Formulation Integrity: Why Fillers Are a Real Problem
Many commercial probiotics contain inactive excipients that have no business being in a gut health product. Microcrystalline cellulose (MCC) is one of the most common fillers in the supplement industry, used to add bulk and aid manufacturing flow—and there is emerging evidence that it may affect gut mucosal integrity at relevant doses. Magnesium stearate, a flow agent, is similarly ubiquitous. Neither belongs in a product whose entire purpose is to improve gut health.
Probiotic for Constipation: What to Look For vs. What to Avoid
Look for: Named strains at species and subspecies level; Bifidobacterium lactis, L. reuteri, B. longum, L. acidophilus, and L. rhamnosus among the strains listed; incorporated prebiotic fibers (certified organic where possible); pullulan or delayed-release capsule technology; transparent CFU count (15 billion+ for comprehensive coverage); no unnecessary excipients.
Avoid: Genus-only labeling ("Bifidobacterium spp."); microcrystalline cellulose, magnesium stearate, or titanium dioxide in the inactive ingredients; flow agents and synthetic additives; products with only 1–3 strains for a multi-faceted condition like chronic constipation; proprietary blends that obscure individual strain CFU counts.

How Long Before Probiotics Work for Constipation?
This is one of the most common questions—and the clinical trials provide some useful benchmarks. In the L. reuteri RCT in adults, meaningful improvements in bowel movement frequency were observed at week four.[3] The B. longum RCT in elderly patients showed significant stool frequency improvement within a four-week intervention as well.[4] Across the broader probiotic and constipation literature, trial durations typically run 4–12 weeks, with most responders showing improvement within the first month.

Some context is important here. Probiotic colonization is transient for most strains—they don't permanently take up residence in your gut ecosystem, but rather shift conditions during supplementation in ways that can have lasting effects. This is why consistency matters: daily supplementation over at least 4 weeks is a reasonable minimum before drawing conclusions about efficacy for constipation. The best time to take probiotics also affects how well strains survive transit and colonize the colon—our article on this covers the timing evidence in detail.
When to Consult Your Healthcare Provider
Probiotics are well-established as safe for healthy adults. However, if your constipation is severe, long-standing, or accompanied by symptoms like blood in the stool, unexplained weight loss, or significant pain, these warrant evaluation by a clinician before starting any supplement protocol. Probiotics are an adjunct to gut health management—not a substitute for medical care when serious pathology may be present. Individuals with compromised immune systems should also consult a healthcare provider before beginning probiotic supplementation.
Frequently Asked Questions

What is the most effective probiotic for constipation?
Based on the current clinical literature, Bifidobacterium lactis has the strongest single-strain evidence for increasing stool frequency in adults with chronic constipation—identified specifically in a 30-RCT meta-analysis as having a significant effect that was not found for other individual strains tested.[2] Lactobacillus reuteri also has strong evidence for increasing bowel movement frequency in RCTs.[3] In practice, multi-strain formulas that include both Bifidobacterium and Lactobacillus species tend to produce broader and more sustained benefits than single-strain products, which is why a product like MicroBiome Restore—which contains both strains alongside 24 others—provides more comprehensive coverage.
Can probiotics make constipation worse before it gets better?
A small proportion of users experience a brief adjustment period—typically mild bloating or gas—during the first 1–2 weeks of starting a new probiotic. This generally reflects the microbiome shifting in response to the new bacterial populations and their metabolic activity. It is not constipation worsening, but rather a transient fermentation adjustment. If symptoms persist beyond two weeks or are significant, the dose can be reduced and increased gradually.
Do probiotics help with constipation caused by IBS?
Yes—this is one of the most studied applications. IBS with constipation (IBS-C) is characterized by dysbiosis, altered gut motility, and often elevated markers of gut inflammation. Multiple RCTs and meta-analyses have shown probiotic benefit for IBS-C symptoms including stool consistency, frequency, and abdominal discomfort.[10][11] Our article on probiotics for IBS covers the strain-specific evidence for this condition in depth.
Are probiotics safe to take long-term for constipation?
For healthy adults, probiotics are considered safe for long-term daily use. The clinical trials referenced in this article used intervention periods of 4–12 weeks without significant adverse events. Systemic absorption of probiotic bacteria is rare in immunocompetent individuals. As with any supplement, those with autoimmune conditions, inflammatory bowel disease, or who are immunosuppressed should consult a healthcare provider before long-term use.
Should you take probiotics with GLP-1 medications?
GLP-1 receptor agonists (like semaglutide) slow gastric emptying as part of their mechanism of action, which can cause or worsen constipation in some users. The gut microbiome changes associated with GLP-1 use are still being characterized, but there is emerging interest in whether probiotic supplementation can offset some of the gastrointestinal side effects of these medications, including constipation and nausea. Currently there is no specific contraindication between probiotics and GLP-1 agents. If you're experiencing constipation on a GLP-1 medication, speak with your prescribing provider before adding any supplement.
How is a probiotic for constipation different from a laxative?
Laxatives work mechanically—by drawing water into the stool, stimulating muscle contractions, or softening stool. They address the output but not the underlying cause. Probiotics work by restoring the microbial ecosystem that regulates gut motility in the first place—supporting SCFA production, serotonin synthesis, and enteric nervous system function.[6] The difference is symptomatic relief versus root-cause rebalancing. Laxatives may be necessary in the short term; probiotics are a longer-term strategy for sustained regularity.
Achieving Lasting Regularity with Evidence-Based Probiotic Support
Constipation is not simply a problem of not eating enough fiber. The clinical evidence now clearly positions the gut microbiome as a central driver of intestinal motility—and probiotics as one of the few interventions that addresses that root cause directly. A 2024 meta-analysis confirmed that probiotics are statistically and clinically superior to placebo for constipation management.[1] A broader meta-analysis from King's College London showed 57% of probiotic users responding versus 44% on placebo across 30 RCTs, with Bifidobacterium lactis identified as the standout single strain.[2]
What matters, then, is choosing a probiotic that reflects this evidence: multiple strains spanning both Bifidobacterium and Lactobacillus genera, organic prebiotic support that fuels SCFA production and strain colonization, and a formulation free of the fillers and excipients that have no business being in a gut health product. For a full breakdown of how MicroBiome Restore was built around these principles, see our complete guide to MicroBiome Restore.
If you're also dealing with bloating alongside constipation, or if your symptoms point toward a broader dysbiosis pattern, our gut dysbiosis guide and post-antibiotic recovery guide offer additional context. Regular bowel function is one of the most basic measures of gut health—and the right probiotic stack can make a meaningful, measurable difference.
26 Strains. 7 Certified Organic Prebiotics. Zero Fillers.
MicroBiome Restore is built on the same evidence reviewed in this article—with every constipation-relevant strain paired with the prebiotic fibers that activate their motility-supporting mechanisms. Made in the USA. No MCC. No magnesium stearate. No titanium dioxide.
References
- Garzon Mora, N., Jaramillo, A. P., et al. (2024). Effectiveness of probiotics in patients with constipation: A systematic review and meta-analysis. Cureus, 16(1), e52013. https://doi.org/10.7759/cureus.52013
- van der Schoot, A., Helander, C., Whelan, K., & Dimidi, E. (2022). Probiotics and synbiotics in chronic constipation in adults: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition, 41(12), 2759–2777. https://doi.org/10.1016/j.clnu.2022.10.015
- Ojetti, V., Ianiro, G., Tortora, A., D'Angelo, G., Di Rienzo, T. A., Bibbò, S., Migneco, A., & Gasbarrini, A. (2014). The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: A randomized, double-blind, placebo-controlled trial. Journal of Gastrointestinal and Liver Diseases, 23(4), 387–391. https://pubmed.ncbi.nlm.nih.gov/25531996/
- Takeda, T., Asaoka, D., Nojiri, S., Yanagisawa, N., Nishizaki, Y., Osada, T., Koido, S., Nagahara, A., Katsumata, N., Odamaki, T., Xiao, J.-Z., & Ohkusa, T. (2023). Usefulness of Bifidobacterium longum BB536 in elderly individuals with chronic constipation: A randomized controlled trial. American Journal of Gastroenterology, 118(3), 561–568. https://doi.org/10.14309/ajg.0000000000002028
- Zhao, Y., Yu, Y.-B. (2021). Role of gut microbiota in functional constipation. Gastroenterology Report, 9(5), 392–401. https://doi.org/10.1093/gastro/goab035
- Dimidi, E., Christodoulides, S., Scott, S. M., & Whelan, K. (2017). Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Advances in Nutrition, 8(3), 484–494. https://doi.org/10.3945/an.116.014407
- Cheng, J., Laitila, A., & Ouwehand, A. C. (2021). Bifidobacterium animalis subsp. lactis HN019 effects on gut health: A review. Frontiers in Nutrition, 8, 790561. https://doi.org/10.3389/fnut.2021.790561
- Wei, X., Tao, J., Xiao, S., et al. (2023). Lactobacillus reuteri in digestive system diseases: Focus on clinical trials and mechanisms. Frontiers in Cellular and Infection Microbiology, 13, 1254198. https://doi.org/10.3389/fcimb.2023.1254198
- Indiani, C. M. D. S. P., Rizzardi, K. F., Castelo, P. M., et al. (2022). Clinical assessment and cytokines level in constipation-predominant irritable bowel syndrome participants treated with Lactobacillus-containing cultured milk drink. Frontiers in Nutrition, 8, 795554. https://pubmed.ncbi.nlm.nih.gov/34965040/
- Preston, K., Krumian, R., Hattner, J., de Montigny, D., Stewart, M., & Gaddam, S. (2018). Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: A double-blind, randomised, placebo-controlled study. Beneficial Microbes, 9(5), 697–706. https://doi.org/10.3920/BM2017.0105
- Liu, H. N., Wu, H., Chen, Y. Z., Chen, Y. J., Shen, X. Z., & Liu, T. T. (2022). Efficacy of probiotics for irritable bowel syndrome: A systematic review and network meta-analysis. Frontiers in Pharmacology, 13, 853011. https://doi.org/10.3389/fphar.2022.853011
- Ringel-Kulka, T., Palsson, O. S., Maier, D., Carroll, I., Galanko, J. A., Leyer, G., & Ringel, Y. (2011). Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: A double-blind study. Journal of Clinical Gastroenterology, 45(6), 518–525. https://pmc.ncbi.nlm.nih.gov/articles/PMC4372813/


Share and get 15% off!
Simply share this product on one of the following social networks and you will unlock 15% off!